1. Introduction {#sec1}
===============

Chronic atrophic gastritis (CAG) is a histopathologic entity characterized by chronic inflammation of the gastric mucosa with loss of gastric glandular cells. CAG, intestinal metaplasia (IM), and epithelial dysplasia (ED) of the stomach are common and are associated with an increased risk of gastric cancer. CAG and IM are considered to be precancerous conditions. ED represents the penultimate stage of the gastric carcinogenesis sequence, defined as histologically unequivocal neoplastic epithelium without evidence of tissue invasion, and is thus a direct neoplastic precancerous lesion. ED is characterized by cellular atypia reflective of abnormal differentiation and disorganized glandular architecture.

*Helicobacter pylori* are Gram-negative bacteria that colonize the human gastric epithelium and represent one of the most common human infections worldwide*. H. pylori*infection is usually contracted in the first few years of life, and its prevalence increases with older age and lower socioeconomic status during childhood \[[@B1]\]. This infection is the primary inducer of CAG, IM, and ED. More than half of all humans have *H. pylori* colonies in their stomachs; however, only a minority of *H. pylori*-infected individuals develop cancer of the stomach \[[@B2]\]. Haziri et al. \[[@B3]\] reported that the prevalence of *H. pylori* infection was high in patients with CAG (66.0%), IM (71.7%), and gastric dysplasia (71.4%). In the present study, the clinical and histopathological characteristics of 3969 CAG patients from our hospital were retrospectively studied, and the relationship between *H. pylori* infection and gastric precancerous conditions was investigated. The results of this study will provide a greater understanding of CAG.

2. Methods {#sec2}
==========

Patients with CAG diagnosed by endoscopy and histological examination from 2007 to 2012 in the First Affiliated Hospital of the College of Medicine at Zhejiang University were included in the study. One or two biopsies from the antrum were taken, and the slides were stained with hematoxylin and eosin. Cases in which *H. pylori* were identified in any of the biopsy specimens were considered positive. The presence of atrophy was assessed according to the updated Sydney System classification \[[@B4]\].

Fisher\'s exact test was used to compare the proportions of different characteristics between groups, and *P* values \<0.05 were considered statistically significant.

3. Results {#sec3}
==========

There were 3969 adult patients (2051 males and 1918 females) with CAG enrolled, whose age ranged from 18 to 94 years. The distribution of the different stages of CAG, IM, and ED of the stomach according to age is shown in [Table 1](#tab1){ref-type="table"}. In 196 cases of young adults (≤40 years), 2639 cases of middle-aged adults (41−65 years), and 1134 cases of older adults (≥66 years), the*H. pylori* infection (33.67%, 21.94%, and 16.67%), and inflammatory activity (39.8%, 31.45%, and 26.7%) decreased with age (also see in [Table 1](#tab1){ref-type="table"} and [Figure 1](#fig1){ref-type="fig"}). The presence of IM with young adulthood, middle and old age (80.61%, 83.86%, and 86.07%) and ED (2.04%, 3.07%, and 4.32%) in CAG patients increased with age (see also in [Table 1](#tab1){ref-type="table"}).

3.1. *H. pylori* and Inflammatory Activity {#sec3.1}
------------------------------------------

There were 834 subjects (21.01%) with *H. pylori* infection; among these patients, 770 subjects (92.33%) had simultaneous inflammatory activity ([Table 2](#tab2){ref-type="table"}). *H. pylori* positivity was 63.48% in patients with inflammatory activity, which was significantly higher than that of those without inflammatory activity (2.32%). Only 7.67% of *H. pylori*-infected patients were negative for inflammatory activity. *H. pylori* infection was significantly correlated with inflammatory activity (*P* ≤ 0.01; [Table 3](#tab3){ref-type="table"}).

3.2. *H. pylori* and Precancerous Gastric Lesions {#sec3.2}
-------------------------------------------------

The percentage of *H. pylori* infection and inflammatory activity among 164 subjects with severe CAG was 12.80% and 23.17%, respectively, which was significantly lower than that of the mild (20.65% and 29.07%) and moderate (22.46% and 33.62%) CAG patients ([Table 4](#tab4){ref-type="table"}).

The *H. pylori* positivity rate in the CAG patients with IM was 20.26%, which was significantly lower than those without IM (25.08%; *P* ≤ 0.05) ([Table 5](#tab5){ref-type="table"}). The *H. pylori* positivity was not significantly different between the CAG patients with ED and those without ED ([Table 6](#tab6){ref-type="table"}).

3.3. Gastric Atrophy, Intestinal Metaplasia and Epithelial Dysplasia {#sec3.3}
--------------------------------------------------------------------

IM was present in 84.33% and ED was present in 3.38% of patients with CAG. The IM and ED notably increased in positive association with more severe grade of gastric atrophy ([Table 4](#tab4){ref-type="table"}). IM and ED appeared not to correlate with each other (Tables [5](#tab5){ref-type="table"} and [6](#tab6){ref-type="table"}).

4. Discussion {#sec4}
=============

*H. pylori* colonizes the stomach of more than half of the world\'s population, and this infection continues to play a key role in the pathogenesis of a number of gastroduodenal diseases \[[@B5]\]. It is hence classified as a Group A carcinogen by the World Health Organization. Epidemiological studies have determined that the attributable risk of gastric cancer conferred by *H. pylori* infection is approximately 75% \[[@B6]\]. Although evidence is emerging that the prevalence of *H. pylori* is declining in all age groups, the understanding of its disease spectrum continues to evolve \[[@B7]\].

Our study compared the *H. pylori* infection and gastric precancerous conditions in CAG by histological examination. We analyzed the presence of *H. pylori* infection in patients of different ages and found that the incidence of *H. pylori* infection decreased with age. However, several studies showed that the prevalence of *H. pylori* infection increased with age in general population in developing and developed countries \[[@B8]--[@B10]\], and few studies focused on *H. pylori* infection and age in atrophic patients. We also found that 92.33% of the *H. pylori*-positive patients had simultaneous inflammatory activity, which demonstrated a statistically significant relationship between *H. pylori* infection and neutrophil activation. These results are consistent with those of Khulusi et al. \[[@B11]\], as *H. pylori* infection could result in neutrophil activation and chronic gastritis \[[@B12]\].

Loss of normal glandular tissue is the first specific recognizable step in the precancerous cascade of gastric carcinoma \[[@B13]\]. Chronic *H. pylori*-induced inflammation can eventually lead to the loss of the normal gastric mucosal architecture, with destruction of the gastric glands and replacement by fibrosis and intestinal-type epithelium. This process of CAG and IM occurs in approximately half of the *H. pylori*-colonized population at sites in which inflammation is most severe \[[@B14]\]. The risk of CAG development depends on the distribution and pattern of chronic active inflammation.

Our study showed a low prevalence (21.01%) of *H. pylori* infection in all of the antral CAG patients, and the positivity rate decreased with growing severity of gastric atrophy. *H. pylori* infection is an established risk factor for CAG. Weck et al. reported that the odds ratio for the association between CAG and *H. pylori* infection alone was 2.9 (95% confidence interval: 2.3−3.6) \[[@B15]\]. What caused the low prevalence of *H. pylori* infection in the CAG patients in our study, particularly in those with severe atrophy? *H. pylori* colonization of the gastric mucosa may persist for decades or for life, unless it is eradicated by antimicrobial treatment. Perhaps the clearance of *H. pylori* infection in advanced stages of the disease is responsible for this finding. Alternatively, there is some evidence that the prevalence of these infections is declining in countries that have been rapidly developing economically, resulting from an associated improvement in the standard of living \[[@B16]\].

IM represents a phenotypic change from that of the normal epithelial cells of the gastric mucosa to an intestinal phenotype. It is considered to be an advanced stage of atrophy because the original glands, are replaced by metaplastic glands and chronologically, the metaplastic glands appear after the gastric glands are lost. In the present study, the majority of the CAG patients presented with IM. Furthermore, IM correlated significantly with the severity of CAG. ED is characterized by a neoplastic phenotype, both in terms of cell morphology and architectural organization. In the current study, the prevalence of ED increased with the progression of CAG. Evolution into gastric cancer was documented for all grades of dysplasia and correlated significantly with severe CAG \[[@B17]\].

Taken together, this study has shown that the incidence of *H. pylori* infection decreased with age and correlated significantly with inflammatory activity in CAG patients. IM and ED positivity notably increased as the degree of gastric atrophy increased. Although significant findings were revealed in the present analysis of the clinical and pathological characteristics of 3969 CAG cases, there were some limitations to our study. Only a histological examination of *H. pylori* infection was performed, which may have decreased the *H. pylori*detection rate. Further large population-based prospective studies are needed to better understand the progression of CAG.
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###### 

The clinical and pathological characteristics of 3969 cases of atrophic gastritis according to age group.

  Age (years)   Cases (*N*)   Gender   Gastric atrophy   Intestinal metaplasia   Dysplasia   *H. pylori*infection   Inflammatory activity                                                                  
  ------------- ------------- -------- ----------------- ----------------------- ----------- ---------------------- ----------------------- ------- ------ ----- ------ ----- ---- --- ------ ----- ------ ------
  ≤29           28            15       13                20                      5           3                      8                       10      6      4     27     1     0    0   18     10    16     12
  30--39        129           75       54                72                      52          5                      20                      35      55     19    128    1     0    0   85     44    77     52
  40--49        605           333      272               380                     212         13                     104                     158     270    73    585    19    1    0   465    140   407    198
  50--59        1296          637      659               747                     507         42                     224                     331     529    212   1259   32    5    0   991    305   864    432
  60--69        1106          567      539               634                     417         55                     142                     306     475    183   1067   29    8    2   887    219   794    312
  70--79        689           350      339               388                     269         32                     107                     192     271    119   657    26    3    3   593    96    519    170
  ≥80           116           74       42                50                      52          14                     17                      25      46     28    112    3     1    0   96     20    79     37
                                                                                                                                                                                                           
  Total         3969          2051     1918              2291                    1514        164                    622                     1057    1652   638   3835   111   18   5   3135   834   2756   1213
  *P*                         0.134    0.000             0.048                   0.468                              0.000                   0.000                                                          

###### 

The distribution of inflammatory (neutrophil) activity, gastric atrophy, intestinal metaplasia, and dysplasia according to the presence or absence of *H. pylori* infection.

  *H. pylori* infection   Cases (*N*)   Gender         Inflammatory activity   Gastric atrophy   Intestinal metaplasia   Dysplasia                                                                                                                                 
  ----------------------- ------------- -------------- ----------------------- ----------------- ----------------------- -------------- -------------- ------------ ------------- -------------- ------------- ------------ -------------- ----------- ----------- ----------
  Negative (%)            3135          1623 (51.77)   1512 (48.23)            2692 (85.87)      443 (14.13)             1818 (57.99)   1174 (37.45)   143 (4.56)   466 (14.87)   1988 (63.41)   564 (17.99)   117 (3.73)   3022 (96.40)   93 (2.97)   15 (0.48)   5 (0.15)
  Positive (%)            834           428 (51.32)    406 (48.68)             64 (7.67)         770 (92.33)             473 (56.71)    340 (40.77)    21 (2.52)    156 (18.71)   570 (68.34)    74 (8.87)     34 (4.08)    813 (97.48)    18 (2.16)   3 (0.36)    0 (0)
                                                                                                                                                                                                                                                                   
  Total                   3969          2051           1918                    2756              1213                    2291           1514           164          622           2558           638           151          3835           111         18          5
  *P*                                   0.817          0.000                   0.013             0.000                   0.368                                                                                                                                     

Note. The numbers in parentheses represent the percentage of inflammatory activity, gastric atrophy, intestinal metaplasia, and dysplasia in the *H. pylori-*negative and -positive groups.

###### 

The distribution of *H. pylori*infection, gastric atrophy, intestinal metaplasia, and dysplasia according to the presence or absence of inflammatory activity.

  Inflammatory activity   Cases (*N*)   Gender         *H. pylori*infection   Gastric atrophy   Intestinal metaplasia   Dysplasia                                                                                                                                 
  ----------------------- ------------- -------------- ---------------------- ----------------- ----------------------- -------------- -------------- ------------ ------------- -------------- ------------- ------------ -------------- ----------- ----------- ----------
  Negative (%)            2756          1399 (50.76)   1357 (49.24)           2692 (97.68)      64 (2.32)               1625 (58.96)   1005 (36.47)   126 (4.57)   414 (15.02)   1763 (63.97)   476 (17.27)   103 (3.74)   2655 (96.34)   85 (3.08)   12 (0.44)   4 (0.14)
  Positive (%)            1213          652 (53.75)    561 (46.25)            443 (36.52)       770 (63.48)             666 (54.91)    509 (41.96)    38 (3.13)    208 (17.15)   795 (65.54)    162 (13.36)   48 (3.95)    1180 (97.28)   26 (2.14)   6 (0.50)    1 (0.08)
                                                                                                                                                                                                                                                                  
  Total                   3969          2051           1918                   3135              834                     2291           1514           164          622           2558           638           151          3835           111         18          5
  *P*                                   0.083          0.000                  0.001             0.020                   0.381                                                                                                                                     

Note. The numbers in parentheses represent the percentage of *H. pylori infection*, gastric atrophy, intestinal metaplasia, and dysplasia in the inflammatory activity-negative and -positive groups.

###### 

The distribution of *H. pylori* infection, inflammatory (neutrophil) activity, intestinal metaplasia and dysplasia according to the grade of gastric atrophy.

  Gastric atrophy   Cases (*N*)   Gender   *H. pylori* infection   Inflammatory activity   Intestinal metaplasia   Dysplasia                                              
  ----------------- ------------- -------- ----------------------- ----------------------- ----------------------- ----------- -------------- ----- -------------- ------ ------------
  Mild (%)          2291          1144     1147                    1818                    473 (20.65)             1625        666 (29.07)    496   1795 (78.35)   2230   61 (2.66)
  Moderate (%)      1514          821      693                     1174                    340 (22.46)             1005        509 (33.62)    117   1397 (92.27)   1453   61 (4.03)
  Severe (%)        164           86       78                      143                     21 (12.80)              126         38 (23.17)     9     155 (94.51)    152    12 (7.32)
                                                                                                                                                                          
  Total (%)         3969          2051     1918                    3135                    834 (21.01)             2756        1213 (30.56)   622   3347 (84.33)   3835   134 (3.38)
  *P*                             0.034    0.013                   0.001                   0.000                   0.000                                                  

Note. The numbers in parentheses represent the percentage of *H. pylori* infection, inflammatory activity, intestinal metaplasia and dysplasia in patients with different degrees of gastric atrophy.

###### 

The distribution of *H. pylori* infection, inflammatory (neutrophil) activity, gastric atrophy, and dysplasia according to the presence or absence of intestinal metaplasia.

  Intestinal metaplasia   Cases (*N*)   Gender   *H. pylori* infection   Inflammatory activity   Gastric atrophy   Dysplasia                                                                    
  ----------------------- ------------- -------- ----------------------- ----------------------- ----------------- ----------- -------------- -------------- -------------- ------------ ------ ------------
  Negative (%)            622           271      351                     466                     156 (25.08)       414         208 (33.44)    496 (79.74)    117 (18.81)    9 (1.45)     606    16 (2.57)
  Positive (%)            3347          1780     1567                    2669                    678 (20.26)       2342        1005 (30.03)   1795 (53.63)   1397 (41.74)   155 (4.63)   3229   118 (3.53)
                                                                                                                                                                                                
  Total (%)               3969          2051     1918                    3135                    834 (21.01)       2756        1213 (30.56)   2291 (57.72)   1514 (38.15)   164 (4.13)   3835   134 (3.38)
  *P*                                   0.000    0.000                   0.02                    0.000             0.513                                                                        

Note. The numbers in parentheses represent the percentage of *H. pylori* infection, inflammatory activity, gastric atrophy, and dysplasia in the intestinal metaplasia-negative and -positive groups.

###### 

The distribution of *H. pylori* infection, inflammatory (neutrophil) activity, gastric atrophy and intestinal metaplasia according to the presence or absence of dysplasia.

  Dysplasia      Cases (*N*)   Gender   *H. pylori* infection   Inflammatory activity   Gastric atrophy   Intestinal metaplasia                                                                   
  -------------- ------------- -------- ----------------------- ----------------------- ----------------- ----------------------- -------------- -------------- -------------- ------------ ----- --------------
  Negative (%)   3835          1966     1869                    3022                    813 (21.20)       2655                    1180 (30.77)   2230 (58.15)   1453 (37.89)   152 (3.96)   606   3229 (84.2)
  Positive (%)   134           85       49                      113                     21 (15.67)        101                     33 (24.63)     61 (45.52)     61 (45.52)     12 (8.96)    16    118 (88.06)
                                                                                                                                                                                                  
  Total (%)      3969          2051     1918                    3135                    834 (21.01)       2756                    1213 (30.56)   2291 (57.72)   1514 (38.15)   164 (4.13)   622   3347 (84.33)
  *P*                          0.031    0.368                   0.381                   0.000             0.513                                                                                   

Note. The numbers in parentheses represent the percentage of *H. pylori* infection, inflammatory activity, gastric atrophy and intestinal metaplasia in the dysplasia-negative and -positive groups.
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